Perceptive-linked holders report 3.97M shares of Zymeworks (ZYME)
Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G
Rhea-AI Filing Summary
Zymeworks Inc. reports a Schedule 13G filing showing Perceptive-linked holders beneficially own 3,974,579 shares of Common Stock. The filing states this equals 5.4% of the class based on 73,749,607 shares outstanding as of February 26, 2026. Perceptive Life Sciences Master Fund directly holds the shares; Perceptive Advisors and Joseph Edelman are reported as investment manager and managing member, respectively.
Positive
- None.
Negative
- None.
Key Figures
Shares beneficially owned: 3,974,579 shares
Percent of class: 5.4%
Shares outstanding: 73,749,607 shares
+1 more
4 metrics
Shares beneficially owned
3,974,579 shares
Direct holding by Perceptive Life Sciences Master Fund
Percent of class
5.4%
Calculated by reporting persons based on outstanding shares
Shares outstanding
73,749,607 shares
As of <date>February 26, 2026</date> per company 10-K cited in filing
CUSIP
98985Y108
Identifies Zymeworks common stock in the filing
Key Terms
Schedule 13G, Beneficially own, Shared dispositive power, CUSIP
4 terms
Schedule 13G regulatory
"The names of the persons filing this report (collectively, the "Reporting Persons")"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
Beneficially own financial
"The Master Fund directly holds 3,974,579 shares of Common Stock"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
CUSIP technical
"Common Stock, $0.00001 par value per share 98985Y108"
A CUSIP is a nine-character alphanumeric code that uniquely identifies a U.S. or Canadian financial security—such as a stock, bond, or fund share—like a Social Security number for an investment. It matters to investors because brokers, exchanges and record-keepers use the CUSIP to match trades, track ownership, settle transactions and pull accurate records, reducing errors and ensuring money and securities go to the right place.
FAQ
What stake does Perceptive Advisors hold in ZYME?
Perceptive Advisors is reported to beneficially own 3,974,579 shares (5.4%). The filing says Perceptive Advisors serves as investment manager and may be deemed to beneficially own the Master Fund's shares held directly.
When was the Schedule 13G signed and who signed it?
The joint filing agreement and cover pages are signed by Joseph Edelman as Managing Member, with signature dates of 04/15/2026. The cover page lists the CUSIP 98985Y108 and class as Common Stock.